NCV Logo

NCV LINKS

National Institutes of Health U.S. Department of Health and Human Services - National Institutes of Health
National Center for Research Resources National Center for Research Resources

Georgette D. Kanmogne, Ph.D. MPH

Assistant Professor
Department of Pharmacology and Experimental Neuroscience
Senior Scientist / Center for Neurovirology and Neurodegenerative Disorders
University of Nebraska Medical Center
Omaha NE 68198-5215
Tel: 402-559-4084
Fax: 402-559-8922
Email: gkanmogne@unmc.edu

Research Goals:

  • Vascular Biology of HIV infection.
  • Mechanisms of HIV-mediated Blood-brain barrier dysfunction and HIV invasion of the brain.
  • Mechanisms of HIV-mediated lung injury and AIDS pulmonary complications

Techniques

  • Tissue culture, ELISA
  • Immunohistochemistry
  • Laser Confocal Microscopy
  • Cell Migration Assays
  • Southern & Western blot analysis
  • Autoradiography
  • Microarray & proteomics
  • PCR, RT-PCR, Real -Time PCR

In vivo studies

  • Development an animal model (Hu PBL-NOD/SCID mice) for HIV-1 Lymphocytic Alveolitis

Selected publications

  1. Kanmogne, G.D., Primeaux, C and Grammas, P. (2005). Induction of apoptosis and endothelin-1 secretion in primary human lung endothelial cells by HIV-1 gp120 proteins. Biochem Biophys Res Commun 333: 1107-1115

  2. Kanmogne, G.D., Primeaux, C and Grammas, P. (2005). HV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: Implications for the pathogenesis of HIV-associated dementia. J. Neuropathol. Exp. Neurol. 64 (6), 498-505

  3. Kanmogne, G.D. (2005) Noninfectious pulmonary complications of HIV/AIDS. Curr Opin Pulm Med 11, 208-212.

  4. Kanmogne, G.D., Kennedy, R.C and Grammas, P. (2003). Is HIV involved in the pathogenesis of non-infectious pulmonary complications in infected patients? Current HIV Research 1(3), 385-393.

  5. Kanmogne, G.D., Kennedy, R.C and Grammas, P. (2002). HIV-1 gp120 proteins and gp160 peptides are toxic to brain endothelial cells and neurons: possible pathway for HIV entry into the brain and HIV-associated dementia. Journal of Neuropathology and Experimental Neurology 61(11), 992-1000.

  6. Kanmogne, G.D., Kennedy, R.C, and Grammas, P. (2002). Infection of baboon microglia with SIV/HIV recombinant viruses: role of CD4 and chemokine receptors. AIDS Research and Human Retroviruses 18 (8), 557-565.

  7. Kanmogne, G.D., Kennedy, R.C, and Grammas, P. (2001) Analysis of human lung endothelial cells for susceptibility to HIV Type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. AIDS Research and Human Retroviruses 17 (1), 45-53.

  8. Kanmogne, G.D., Grammas, P. and Kennedy, R.C. (2000). Analysis of human endothelial cells and cortical neurons for susceptibility to HIV-1 infection and coreceptor expression. Journal of Neurovirology 6, 519-528.

  9. Sarkodie, Y.A., Sangare, K.A., D’Almeida, O.A. and Kanmogne, G.D.  (1998) Distribution of CD4+ cell levels in patients with clinical AIDS, but without HIV antibodies in 3 West-African countries.  Journal of Clinical Virology 11, 173-181.

  10. Kanmogne, G., A. Sangare, O. d’Almeida, Y. Adu-Sarkodie, F. Davies, H. Lee and J-P Allain.  (1998) Human T-cell leukaemia/lymphoma virus type I infection in West African patients with clinical AIDS.  AIDS 12 (16), 223.